SCHEMBL1664256

SCHEMBL1664256

CC(OC(=O)C1CC=CC(C)C1C(=O)O)c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCAR2 Q8TDS4 1/20 0.40
GRIN2B Q13224 1/20 0.35
CYP3A4 P08684 3/20 0.35
CYP1A2 P05177 3/20 0.35
HSD17B10 Q99714 2/20 0.35
TSHR P16473 2/20 0.35
CYP2D6 P10635 1/20 0.35
MAPK1 P28482 1/20 0.35
POLB P06746 3/20 0.35
CTDSP1 Q9GZU7 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
S1PR5 Q9H228 2/20 0.34
S1PR1 P21453 1/20 0.34
ALDH1A1 P00352 2/20 0.34
LMNA P02545 2/20 0.34
NAAA Q02083 1/20 0.34
BRD4 O60885 2/20 0.33
CREBBP Q92793 2/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1664255 0.95 HCAR2 (0.40) HCAR2GRIN2BCYP3A4CYP1A2HSD17B10
SCHEMBL1664723 0.83 HCAR2 (0.49) HCAR2GRIN2BCYP3A4CYP1A2HSD17B10
SCHEMBL1665066 0.82 PPARG (0.38) TSHRMAPK1TDP1LMNA
SCHEMBL1664724 0.82 POLB (0.45) HCAR2CYP3A4CYP1A2HSD17B10TSHR
SCHEMBL7873893 0.82 POLB (0.48) HCAR2GRIN2BHSD17B10POLBCTDSP1
SCHEMBL1664112 0.79 PRSS1 (0.37) HCAR2CYP3A4MAPK1ALDH1A1LMNA
SCHEMBL1667292 0.76 HCAR2 (0.40) HCAR2GRIN2BCYP3A4CYP1A2HSD17B10
SCHEMBL9179049 0.75 HCAR2 (0.44) HCAR2GRIN2BS1PR5S1PR1ALDH1A1
SCHEMBL1901950 0.75 POLB (0.48) POLBCTDSP1TDP1ALDH1A1LMNA
SCHEMBL11766935 0.75 POLB (0.48) POLBCTDSP1TDP1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011071674-A1 ASYMMETRIC CYCLIC DIESTER COMPOUNDS FERRO CORPORATION (US) 2011-06-16 WO disclosed
EP-2307476-A1 ASYMMETRIC CYCLIC DIESTER COMPOUNDS FERRO CORPORATION (US) 2011-04-13 EP disclosed
US-20100113664-A1 Asymmetric Cyclic Diester Compounds FERRO CORPORATION (US) 2010-05-06 US disclosed
WO-2009152068-A1 ASYMMETRIC CYCLIC DIESTER COMPOUNDS FERRO CORPORATION (US) 2009-12-17 WO disclosed
US-20090312470-A1 Asymmetric Cyclic Diester Compounds FERRO CORPORATION (US) 2009-12-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090312470-A1 Asymmetric Cyclic Diester Compounds DDT, PCNA, AADAC HCAR2 1123/4885GRIN2B 3747/4885CYP3A4 113/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.